157 related articles for article (PubMed ID: 8244180)
1. Salvage therapy in ovarian cancer: is there a role for intraperitoneal drug delivery?
Markman M
Gynecol Oncol; 1993 Oct; 51(1):86-9. PubMed ID: 8244180
[TBL] [Abstract][Full Text] [Related]
2. Evidence supporting the superiority of intraperitoneal cisplatin compared to intraperitoneal carboplatin for salvage therapy of small-volume residual ovarian cancer.
Markman M; Reichman B; Hakes T; Rubin S; Lewis JL; Jones W; Barakat R; Curtin J; Almadrones L; Hoskins W
Gynecol Oncol; 1993 Jul; 50(1):100-4. PubMed ID: 8349150
[TBL] [Abstract][Full Text] [Related]
3. Current status of intraperitoneal therapy for ovarian cancer.
Markman M
Curr Opin Obstet Gynecol; 1993 Feb; 5(1):99-104. PubMed ID: 7678757
[TBL] [Abstract][Full Text] [Related]
4. Intraperitoneal Therapy of Ovarian Cancer.
Markman M
Oncologist; 1996; 1(1 & 2):18-21. PubMed ID: 10387964
[TBL] [Abstract][Full Text] [Related]
5. Role of intraperitoneal chemotherapy in the front-line setting.
Markman M
J Clin Oncol; 2003 May; 21(10 Suppl):145s-148s. PubMed ID: 12743130
[TBL] [Abstract][Full Text] [Related]
6. Intraperitoneal therapy of ovarian cancer.
Markman M
Semin Oncol; 1998 Jun; 25(3):356-60. PubMed ID: 9633848
[TBL] [Abstract][Full Text] [Related]
7. Gynecological malignancies.
Schaebler DL; Schilder RJ; Young RC
Cancer Chemother Biol Response Modif; 1996; 16():564-91. PubMed ID: 8639401
[TBL] [Abstract][Full Text] [Related]
8. A phase II study of intraperitoneal cisplatin and thiotepa in residual ovarian carcinoma: a Gynecologic Oncology Group study.
Feun LG; Blessing JA; Major FJ; DiSaia PJ; Alvarez RD; Berek JS
Gynecol Oncol; 1998 Dec; 71(3):410-5. PubMed ID: 9887240
[TBL] [Abstract][Full Text] [Related]
9. Intraperitoneal chemotherapy in the management of malignant disease.
Markman M
Expert Rev Anticancer Ther; 2001 Jun; 1(1):142-8. PubMed ID: 12113122
[TBL] [Abstract][Full Text] [Related]
10. Ifosfamide in the treatment of ovarian cancer.
Markman M
Semin Oncol; 1996 Jun; 23(3 Suppl 6):47-9. PubMed ID: 8677449
[TBL] [Abstract][Full Text] [Related]
11. An update on the use of intraperitoneal chemotherapy in the management of ovarian cancer.
Markman M
Cancer J; 2009; 15(2):105-9. PubMed ID: 19390303
[TBL] [Abstract][Full Text] [Related]
12. Randomized trial of initial therapy with melphalan versus cisplatin-based combination chemotherapy in patients with advanced ovarian carcinoma: initial and long term results--Eastern Cooperative Oncology Group Study E2878.
Wadler S; Yeap B; Vogl S; Carbone P
Cancer; 1996 Feb; 77(4):733-42. PubMed ID: 8616766
[TBL] [Abstract][Full Text] [Related]
13. Intraperitoneal cisplatin chemotherapy in the management of ovarian carcinoma.
Markman M
Semin Oncol; 1989 Aug; 16(4 Suppl 6):79-82. PubMed ID: 2669140
[TBL] [Abstract][Full Text] [Related]
14. Intraperitoneal chemotherapy for ovarian cancer: overview and perspective.
Rao G; Crispens M; Rothenberg ML
J Clin Oncol; 2007 Jul; 25(20):2867-72. PubMed ID: 17617517
[TBL] [Abstract][Full Text] [Related]
15. Intraperitoneal cisplatin and carboplatin in the management of ovarian cancer.
Markman M
Semin Oncol; 1994 Apr; 21(2 Suppl 2):17-9; quiz 20, 58. PubMed ID: 8202717
[TBL] [Abstract][Full Text] [Related]
16. Medical therapy of advanced malignant epithelial tumours of the ovary.
Colombo N; Parma G; Bocciolone L; Franchi D; Sideri M; Maggioni A
Forum (Genova); 2000; 10(4):323-32. PubMed ID: 11535983
[TBL] [Abstract][Full Text] [Related]
17. [Intraperitoneal chemotherapy in ovarian carcinoma].
Piura B
Harefuah; 2001 Sep; 140(9):844-9, 894, 893. PubMed ID: 11579736
[TBL] [Abstract][Full Text] [Related]
18. Intraperitoneal chemotherapy in ovarian cancer.
Hofstra LS; de Vries EG; Mulder NH; Willemse PH
Cancer Treat Rev; 2000 Apr; 26(2):133-43. PubMed ID: 10772970
[TBL] [Abstract][Full Text] [Related]
19. Intraperitoneal chemotherapy for ovarian cancer.
Hamilton CA; Berek JS
Curr Opin Oncol; 2006 Sep; 18(5):507-15. PubMed ID: 16894301
[TBL] [Abstract][Full Text] [Related]
20. Identification of prognostic factors after positive second-look surgery in epithelial ovarian carcinoma.
McCreath WA; Eisenhauer EL; Abu-Rustum NR; Venkatraman ES; Caceres A; Bier R; Huh J; Cho J; Barakat RR; Chi DS
Gynecol Oncol; 2006 Jul; 102(1):8-14. PubMed ID: 16427689
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]